Adjuvants, ImmunologicAminopyridinesAntineoplastic Combined Chemotherapy Protocols
Dr. Melanie Royce, MD, PhD
NPI1124049366
- Medicare services, 2017
- 15
- Part D claims, 2017
- 97
- Publications
- 36
- Clinical trials
- 6
- Industry payments
- $41,565
- Practice address
- Unm Cancer Ctr, Albuquerque, NM 87131-0001
- Practice phone
- Call (505) 272-4946
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Royce's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Melanie Royce is an internist in Albuquerque, New Mexico
Dr. Royce practices in Albuquerque, New Mexico.
Dr. Royce's NPI, 1124049366, was assigned on July 22, 2006. Dr. Royce holds New Mexico license 2004-0041.
NPI and contact details
- NPI
- 1124049366NPI Registry (opens in a new tab)
- NPI enumeration date
- July 22, 2006
- NPI status
- Active
- Practice phone
- (505) 272-4946
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Melanie Royce's practice address is in Albuquerque, New Mexico
Dr. Royce's practice address in the NPI Registry is Unm Cancer Ctr, Albuquerque, NM 87131-0001. The practice phone is (505) 272-4946.
- NPI Registry addressUnm Cancer Ctr, Albuquerque, NM 87131-0001Phone(505) 272-4946
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Melanie Royce's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Royce practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Royce's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Royce practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Melanie Royce is one of 734 internists in New Mexico
Internal medicine is Dr. Royce's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Royce is licensed in New Mexico.
Specialties and state licenses
- Internal medicine, New MexicoPrimary
Internists near Dr. Royce
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Melanie Royce billed Medicare for 15 services in 2017
CMS data shows 15 Medicare services from Dr. Royce across 1 procedure code in 2017, all of them office visits. Medicare paid $1,221 for them. Every service was in an office.
Medicare services, 201715
Paid by Medicare$1,221
Procedure codes1
Dr. Royce's Medicare services by type, 2016 to 2017
- 2016
- 2017
- Office and hospital visits
- 2016: 2882017: 1595%
Dr. Royce compared with the New Mexico median for internists, 2017
- Dr. Royce
- New Mexico median
- Medicare services
- 15vs 28195% below
- Part D claims
- 97vs 16240% below
Medians across 716 internists in New Mexico with Dmand AI profiles that report each measure.
Dr. Royce's most billed Medicare procedure codes, 2017
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Royce?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Royce and other internists in New Mexico.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Melanie Royce's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Royce's median patient age at 70, with 100% women.
Dr. Royce's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Melanie Royce wrote 97 Medicare Part D claims in 2017
In 2017, Dr. Royce wrote 97 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $8,891 in total drug cost. In 2016, CMS named 235 claims across 8 drugs.
Part D claims, 201797
Drugs named by CMS3
Total drug cost$8,891
Dr. Royce's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2017
- 2016
- 2017
- Claims for drugs CMS names
- 2016: 2352017: 9759%
Drugs named by CMS: 3 in 2017, 8 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find internists like Dr. Royce by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Melanie Royce has 36 publications on record
Dmand AI links 36 papers to Dr. Royce, published from 2010 to 2023. 2016 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Royce has published most often in Breast Cancer Res Treat. Dr. Royce's most frequent co-authors are Christy Lynn Osgood, MD, Zoneddy Ruiz Dayao, MD and Jennifer Gao, MD.
Papers36
Years published2010 to 2023
Dr. Royce's papers by year, 2012 to 2023
Topics Dr. Royce writes about most
- Breast Neoplasms
- Receptor, ErbB-2
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- United States Food and Drug Administration
- Chemotherapy, Adjuvant
- Drug Approval
- Neoadjuvant Therapy
Dr. Royce's most frequent co-authors
- Christy Lynn Osgood, MD7 shared papers
- Zoneddy Ruiz Dayao, MD4 shared papers
- Jennifer Gao, MD4 shared papers
Recent publications by Dr. Royce
AminopyridinesAntineoplastic Combined Chemotherapy ProtocolsBenzimidazoles
Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsClinical Trials, Phase III as Topic
Breast NeoplasmsEthnicityMortality
See who Dr. Royce researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Royce works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Melanie Royce has worked on 6 clinical trials
Dmand AI links Dr. Royce to 6 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Breast Neoplasms, Male. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Royce by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Royce's trials
- Breast Neoplasms
- Breast Diseases
- Breast Neoplasms, Male
- Carcinoma, Intraductal, Noninfiltrating
- Hematologic Neoplasms
Investigators on the most trials with Dr. Royce
- Nabila Chowdhury, MD3 shared trials
- Patrick M. Dillon, MD3 shared trials
- Beverly J. Drucker, MD3 shared trials
Recent clinical trials with Dr. Royce
Breast NeoplasmsBreast Diseases
Breast NeoplasmsBreast DiseasesGM-CSFTrastuzumabNeuVax vaccine
Triple Negative Breast NeoplasmsBrain NeoplasmsCisplatinVeliparib
Hematologic NeoplasmsHematologic DiseasesBGJ398
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Breast Neoplasms, MaleBreast NeoplasmsEverolimusAnastrozoleExemestane
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Melanie Royce received $41,565 in industry payments from 2016 to 2018
CMS Open Payments shows 47 general payments to Dr. Royce from 6 drug and device companies from 2016 to 2018. Travel and lodging make up the largest share, 39% of the total. Novartis Pharmaceuticals Corporation paid the most, $34,849. It also lists 3 research payments totaling $10,184 from 2017 to 2018.
General payments to Dr. Royce by program year, 2016 to 2018
General payments to Dr. Royce by kind, 2016 to 2018
$41.6Kin total
- Travel and lodging$16,26939%
- Consulting fees$14,66935%
- Education speaker fees$9,02222%
- Food and beverage$1,6054%
Companies that paid Dr. Royce the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Melanie Royce's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Melanie Royce
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Melanie Royce's NPI number?
Dr. Melanie Royce's NPI number is 1124049366. It was assigned on July 22, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Melanie Royce?
Dr. Melanie Royce is an internist in Albuquerque, New Mexico. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Melanie Royce practice?
Dr. Royce practices at Unm Cancer Ctr, Albuquerque, NM 87131-0001.
What is Dr. Melanie Royce's office phone number?
The practice phone on file for Dr. Royce is (505) 272-4946.
What is Dr. Melanie Royce's medical license number?
Dr. Royce holds New Mexico license 2004-0041.
Does Dr. Melanie Royce accept Medicare?
Yes. CMS data shows Dr. Royce billed Medicare for 15 services in 2017.
What services does Dr. Melanie Royce bill to Medicare?
In 2017, Dr. Royce's most billed Medicare services were office visit, established patient (99215).
What drugs does Dr. Melanie Royce prescribe most?
In 2017 Medicare Part D data, Dr. Royce's most prescribed drugs by claims were Anastrozole, Letrozole and Enoxaparin Sodium.
Has Dr. Melanie Royce received payments from drug or device companies?
CMS Open Payments shows $41,565 in general payments to Dr. Royce from 6 companies from 2016 to 2018. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Melanie Royce been practicing?
Dr. Royce's NPI was assigned in 2006.
Does Dr. Melanie Royce do research?
Dmand AI links 36 publications to Dr. Royce, published from 2010 to 2023. Dr. Royce has worked on 6 clinical trials.
Who does Dr. Melanie Royce publish with?
Dr. Royce's most frequent co-authors are Christy Lynn Osgood, MD (7 shared papers), Zoneddy Ruiz Dayao, MD (4 shared papers) and Jennifer Gao, MD (4 shared papers).
Selling to internal medicine practices?
See internists in New Mexico by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card